This webinar series will update you on the latest USP developments in Particulate Matter.

This webinar will focus on USP General Chapter <771> and the applicability of USP’s visible (<790>) and subvisible (<788> and <789>) standards to ophthalmic drug products. Discussions will cover the evolution of USP chapters, methods and requirements, concepts of method qualification, and other technical considerations. Participants will be offered the opportunity to ask questions during the last segment of the session.

Subject area:
Drug Products & APIs

Objectives (If applicable):
n/a

Target Audience (If applicable):
Laboratory scientists
Lab managers
QA/QC staff in the pharmaceutical and allied industries
Regulatory professionals
Scientists with interest in Particulate Matter